GLOBOCAN 2022
OROPHARYNX
Incidence Mortality
Rank Cases ASR (World) Rank Deaths ASR (World)
24 106 400 1.1 23 52 305 0.53
Cancer site ranking
Incidence Mortality
Lung Lung
Breast Colorectum
Colorectum Liver
Prostate Breast
Stomach Stomach
Liver Pancreas
Thyroid Oesophagus
Cervix uteri Prostate
Bladder Cervix uteri
NHL Leukaemia
Oesophagus NHL
Pancreas Brain CNS
Leukaemia Bladder
Kidney Ovary
Corpus uteri Lip, oral cavity
Lip, oral cavity Kidney
Melanoma Multiple myeloma
Ovary Larynx
Brain CNS Corpus uteri
Larynx Gallbladder
Multiple myeloma Nasopharynx Oropharynx (23th)
Gallbladder Oropharynx (24th) Melanoma
Nasopharynx Oropharynx 52 305
Oropharynx 106 400 Thyroid
Hypopharynx Hypopharynx
Hodgkin lymphoma Mesothelioma
Testis Salivary glands
Salivary glands Hodgkin lymphoma
Vulva Vulva
Penis Kaposi sarcoma
Kaposi sarcoma Penis
Mesothelioma Testis
Vagina Vagina
0 1.0M 2.0M 3.0M 4.0M 0 500k 1.0M 1.5M 2.0M 2.5M
Number of new cases , both sexes, all ages Number of deaths , both sexes, all ages
Incidence Mortality Prevalence
Continent Cases Percent Continent Deaths Percent Continent Prev. cases Percent
Asia 47 021 44.2% Asia 27 987 53.5% Asia 119 317 39.0%
Europe 29 800 28.0% Europe 13 027 24.9% Europe 96 199 31.4%
Northern America 15 764 14.8% Latin America and the Caribbean 5 310 10.2% Northern America 52 826 17.2%
Latin America and the Caribbean 9 528 9.0% Northern America 3 892 7.4% Latin America and the Caribbean 26 406 8.6%
Africa 3 051 2.9% Africa 1 729 3.3% Africa 7 370 2.4%
Oceania 1 236 1.2% Oceania 360 0.69% Oceania 4 124 1.3%
Incidence, both sexes Mortality, both sexes 5-year prevalence, both sexes
The Global Cancer Observatory | All rights reserved | Globocan 2022 - 08.02.2024 Page 1
Males
–
2.8 9.3 Not applicable
–
1.2 2.8 No data
–
0.6 1.2
–
0.3 0.6
0.0– 0.3
Age standardized (World) incidence rates, Oropharynx, males, all ages
Females
0.5 –2.2 Not applicable
0.3 –0.5 No data
0.1 –0.3
0.0 –
0.1
0.0 –
0.0
Age standardized (World) incidence rates, Oropharynx, females, all ages
Incidence Mortality Males Females
Slovakia (9.3)
Western Europe Eastern Europe
Northern America Northern America
Slovakia (5.1) Moldova (2.1)
Eastern Europe Australia-New Zealand
Northern Europe Western Europe
Australia-New Zealand Caribbean
Denmark (2.2)
Caribbean Northern Europe
South Central Asia Melanesia
South America South Central Asia
Melanesia Polynesia
Southern Europe South America
Polynesia Southern Europe
Southern Africa Southern Africa
South-Eastern Asia Micronesia
Middle Africa South-Eastern Asia
Micronesia Middle Africa
Eastern Asia Eastern Asia
Eastern Africa Eastern Africa
Central America Central America
Western Africa Western Africa
Northern Africa Western Asia
Western Asia Northern Africa
10 8.0 6.0 4.0 2.0 0 2.0 4.0 6.0 8.0 10 20 15 10 5.0 0 5.0 10 15 20
Age-standardized (World) incidence and mortality rates, both sexes, per regions Age-standardized (World) incidence rates per sex, per regions
Page 2
* includes non-melanoma skin cancer (NMSC)
** NMSC included in other cancers
Age standardization using world population (see link)
References
Cancer incidence and mortality data
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:
Website citation GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.
2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.
Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).
Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:
from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].
An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.
© IARC 1965-2024 | All Rights Reserved | https://gco.iarc.who.int | https://gco.iarc.who.int/today
